Status:
COMPLETED
Nexium Capsules Clinical Experience Investigation
Lead Sponsor:
AstraZeneca
Conditions:
Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome
Eligibility:
All Genders
Brief Summary
The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy of Nexium capsules in daily clinical usage for the patients who have been prescribed Nexium for "g...
Detailed Description
Nexium capsules Clinical Experience Investigation
Eligibility Criteria
Inclusion
- Patients treated with Nexium for the first time due to gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
3691 Patients enrolled
Trial Details
Trial ID
NCT01434485
Start Date
September 1 2011
End Date
March 1 2014
Last Update
April 16 2014
Active Locations (47)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aichi, Japan
2
Research Site
Akita, Japan
3
Research Site
Aomori, Japan
4
Research Site
Chiba, Japan